AstraZeneca Pursues FDA Approval for Injectable Lupus Treatment Following European Authorization
AstraZeneca is navigating the final regulatory hurdles for an alternative delivery method of its lupus therapy. As reported by PharmaBiz.com, the company received a complete response letter from the FDA…